As part of a broad effort to invigorate its pipeline and move more aggressively into biotechnology, GoodDrugs Inc. plans to set up a new division dedicated to developing biotherapeutic drugs and research technologies. The company expects to pay $45880099 for set up costs of its new division now and $19627356 in operating costs each year for the next 13 years. The company estimates that the new division will be able to generate annual revenue of $132759017 at 8 years from now. What is the net present worth of this investment if the company's minimum attractive rate of return is 7% per year and the study period is 13 years? Assume there is no salvage value.

Select one:

a. 184122386.12

b. 899640384.14

c. 106883190.03

d. 275882584.12